Literature DB >> 20811367

Antibody-drug conjugates for cancer: poised to deliver?

Bethan Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811367     DOI: 10.1038/nrd3270

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  62 in total

1.  Development of a peptide-drug conjugate for prostate cancer therapy.

Authors:  Wanyi Tai; Ravi S Shukla; Bin Qin; Benyi Li; Kun Cheng
Journal:  Mol Pharm       Date:  2011-05-03       Impact factor: 4.939

2.  Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.

Authors:  E L Carpenter; E A Haglund; E M Mace; D Deng; D Martinez; A C Wood; A K Chow; D A Weiser; L T Belcastro; C Winter; S C Bresler; M Vigny; P Mazot; S Asgharzadeh; R C Seeger; H Zhao; R Guo; J G Christensen; J S Orange; B R Pawel; M A Lemmon; Y P Mossé
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

3.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

4.  A self-assembling short oligonucleotide duplex suitable for pretargeting.

Authors:  Prabodhika Mallikaratchy; Jeffery Gardner; Lars Ulrik R Nordstrøm; Nicholas J Veomett; Michael R McDevitt; Mark L Heaney; David A Scheinberg
Journal:  Nucleic Acid Ther       Date:  2013-07-13       Impact factor: 5.486

Review 5.  Monoclonal antibodies in cancer therapy.

Authors:  Andrew M Scott; James P Allison; Jedd D Wolchok
Journal:  Cancer Immun       Date:  2012-05-01

6.  Pharma interest surges in antibody drug conjugates.

Authors:  Sarah Webb
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

7.  Trial watch: antibody-drug conjugate shows efficacy in lymphoma.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 8.  Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection.

Authors:  S Sadekar; I Figueroa; M Tabrizi
Journal:  AAPS J       Date:  2015-05-02       Impact factor: 4.009

9.  Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate.

Authors:  Shan Yu; Aaron D Pearson; Reyna Kv Lim; David T Rodgers; Sijia Li; Holly B Parker; Meredith Weglarz; Eric N Hampton; Michael J Bollong; Jiayin Shen; Claudio Zambaldo; Danling Wang; Ashley K Woods; Timothy M Wright; Peter G Schultz; Stephanie A Kazane; Travis S Young; Matthew S Tremblay
Journal:  Mol Ther       Date:  2016-10-12       Impact factor: 11.454

Review 10.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.